statistiche ricercatore

Continente	#
NA - Nord America	1.530
EU - Europa	876
AS - Asia	599
SA - Sud America	107
AF - Africa	12
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	3.127

Nazione	#
US - Stati Uniti d'America	1.486
DE - Germania	212
SG - Singapore	205
IT - Italia	168
CN - Cina	162
RU - Federazione Russa	113
SE - Svezia	82
BR - Brasile	81
HK - Hong Kong	79
VN - Vietnam	62
FI - Finlandia	59
GB - Regno Unito	54
IE - Irlanda	52
AT - Austria	35
CA - Canada	34
UA - Ucraina	31
TR - Turchia	18
DK - Danimarca	16
FR - Francia	15
IN - India	15
ID - Indonesia	11
IQ - Iraq	10
NL - Olanda	9
PL - Polonia	8
AR - Argentina	7
ES - Italia	7
JP - Giappone	7
MX - Messico	7
BE - Belgio	6
EC - Ecuador	6
ZA - Sudafrica	6
BD - Bangladesh	5
KR - Corea	5
CO - Colombia	4
CL - Cile	3
IL - Israele	3
TW - Taiwan	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
IR - Iran	2
JO - Giordania	2
KZ - Kazakistan	2
LT - Lituania	2
AU - Australia	1
AZ - Azerbaigian	1
BY - Bielorussia	1
CG - Congo	1
DZ - Algeria	1
EU - Europa	1
GT - Guatemala	1
GY - Guiana	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LU - Lussemburgo	1
MN - Mongolia	1
MU - Mauritius	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
OM - Oman	1
PE - Perù	1
PT - Portogallo	1
PY - Paraguay	1
SC - Seychelles	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	3.127

Nome	#
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	623
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models	360
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG	300
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma	295
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model	287
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities	268
Metabolic evaluation of non-small cell lung cancer patient-derived xenograft models using 18F-FDG PET: A potential tool for early therapy response	266
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis	257
PET imaging as a biomarker of tumor response to therapy	246
Tumour hypoxia: lessons learnt from preclinical imaging	221
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	126
Totale	3.249

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	147	0	0	0	0	0	32	18	15	18	17	20	27
2021/2022	165	13	16	22	11	5	14	10	10	6	15	13	30
2022/2023	296	30	94	33	28	13	45	13	9	22	2	2	5
2023/2024	192	2	10	7	17	29	56	27	6	14	2	3	19
2024/2025	624	37	43	39	24	58	44	83	47	67	77	42	63
2025/2026	680	137	69	83	152	169	70	0	0	0	0	0	0
Totale													3.249

Bicocca Open Archive